Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 May;55(5):937–944. doi: 10.1172/JCI108023

Effects of the 15-methyl analogs of prostaglandins E2 and F2alpha on the pulmonary circulation in the intact dog.

P J Kadowitz, P D Joiner, C S Matthews, A L Hyman
PMCID: PMC301839  PMID: 1123430

Abstract

The effects of the 15-methul analogs of prostaglandins E2 (PGE2) and F2alpha (PGF2alpha) on the pulmonary circulation were studied in the intact dog under conditions of controlled blood flow. Infusions of either analog into the lobar artery increased lobar arterial pressure by more than 100 per cent. The rise in lobar arterial pressure was accompanied by a rise in lobar venous pressure and in pressure gradient from lobar artery to small vein but no change in pressure in the left atrium. The methyl analogs were about 10 times more potent than PGE2 and PGF2alpha in elevating pulmonary vascular resistance in the dog. The effects of the analogs on the pulmonary vascular bed were similar in experiments in which the lung was perfused with dextran or with blood. Both analogs contracted isolated helical segments of canine intrapulmonary artery and vein in a dose-related manner. In other experiments the effects of passive increases in venous pressure produced by distension of a balloon catheter in the lobar vein were contrasted with the action of the analogs on the pulmonary vascular bed. Balloon distension increased pressure in the lobar artery and small vein but had no effect on pressure in the left atrium. However, in contrast to the increase in gradient with the analogs, balloon distension decreased the pressure gradient from lobar artery to small vein. Results of the present study indicate that the prostaglandin analogs increase pulmonary vascular resistance by actively contricting pulmonary veins and vessels upstream to small veins, presumed to be small arteries. It is concluded that the analogs are potent pressor substances in the pulmonary circulation.

Full text

PDF
937

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anggård E., Larsson C., Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand. 1971 Mar;81(3):396–404. doi: 10.1111/j.1748-1716.1971.tb04914.x. [DOI] [PubMed] [Google Scholar]
  2. Anggård E., Samuelsson B. Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. Prostaglandins and related factors. 38. J Biol Chem. 1965 Sep;240(9):3518–3521. [PubMed] [Google Scholar]
  3. BERRY W. B., MCLAUGHLIN J. S., CLARK W. D., MORROW A. G. THE EFFECTS OF ACUTE HYPOXIA ON PRESSURE, FLOW, AND RESISTANCE IN THE PULMONARY VASCULAR BED. Surgery. 1965 Aug;58:404–411. [PubMed] [Google Scholar]
  4. Bergström S., Carlson L. A., Weeks J. R. The prostaglandins: a family of biologically active lipids. Pharmacol Rev. 1968 Mar;20(1):1–48. [PubMed] [Google Scholar]
  5. Berry E. M., Edmonds J. F., Wyllie H. Release of prostaglandin E2 and unidentified factors from ventilated lungs. Br J Surg. 1971 Mar;58(3):189–192. doi: 10.1002/bjs.1800580310. [DOI] [PubMed] [Google Scholar]
  6. Bygdeman M., Béguin F., Toppozada M., Wiqvist N., Bergström S. Intrauterine administration of 15 (S)-15-methyl-prostaglandin F 2 for induction of abortion. Lancet. 1972 Jun 17;1(7764):1336–1337. doi: 10.1016/s0140-6736(72)91061-6. [DOI] [PubMed] [Google Scholar]
  7. Bygdeman M., Martin J. N., Wiqvist N., Gréen K., Bergström S. Reassessment of systemic administration of prostaglandins for induction of midtrimester abortion. Prostaglandins. 1974 Oct 25;8(2):157–169. doi: 10.1016/0090-6980(74)90077-x. [DOI] [PubMed] [Google Scholar]
  8. FEELEY J. W., LEE T. D., MILNOR W. R. ACTIVE AND PASSIVE COMPONENTS OF PULMONARY VASCULAR RESPONSE TO VASOACTIVE DRUGS IN THE DOG. Am J Physiol. 1963 Dec;205:1193–1199. doi: 10.1152/ajplegacy.1963.205.6.1193. [DOI] [PubMed] [Google Scholar]
  9. Ferreira S. H., Vane J. R. Prostaglandins: their disappearance from and release into the circulation. Nature. 1967 Dec 2;216(5118):868–873. doi: 10.1038/216868a0. [DOI] [PubMed] [Google Scholar]
  10. GUYTON A. C., LINDSEY A. W. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res. 1959 Jul;7(4):649–657. doi: 10.1161/01.res.7.4.649. [DOI] [PubMed] [Google Scholar]
  11. Hamberg M., Israelsson U., Samuelsson B. Metabolism of prostaglandin E 2 in guinea pig liver. Ann N Y Acad Sci. 1971 Apr 30;180:164–180. [PubMed] [Google Scholar]
  12. Hyman A. L. Effects of large increases in pulmonary blood flow on pulmonary venous pressure. J Appl Physiol. 1969 Aug;27(2):179–185. doi: 10.1152/jappl.1969.27.2.179. [DOI] [PubMed] [Google Scholar]
  13. Hyman A. L., Pennington D. G., Kadowitz P. J. Effect of acute pulmonary edema on pulmonary arterial pressure in intact dogs. Am J Physiol. 1973 Jan;224(1):35–39. doi: 10.1152/ajplegacy.1973.224.1.35. [DOI] [PubMed] [Google Scholar]
  14. Hyman A. L. The active responses of pulmonary veins in intact dogs to prostaglandins F2 alpha and E1. J Pharmacol Exp Ther. 1969 Feb;165(2):267–273. [PubMed] [Google Scholar]
  15. Hyman A. L., Woolverton W. C., Guth P. S., Ichinose H. The pulmonary vasopressor response to decreases in blood pH in intact dogs. J Clin Invest. 1971 May;50(5):1028–1043. doi: 10.1172/JCI106574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karim S. M., Filshie G. M. The use of prostaglandin E 2 for therapeutic abortion. J Obstet Gynaecol Br Commonw. 1972 Jan;79(1):1–13. doi: 10.1111/j.1471-0528.1972.tb15740.x. [DOI] [PubMed] [Google Scholar]
  17. Lindsey H. E., Wyllie J. H. Release of prostaglandins from embolized lungs. Br J Surg. 1970 Oct;57(10):738–741. doi: 10.1002/bjs.1800571011. [DOI] [PubMed] [Google Scholar]
  18. McGiff J. C., Terragno N. A., Strand J. C., Lee J. B., Lonigro A. J., Ng K. K. Selective passage of prostaglandins across the lung. Nature. 1969 Aug 16;223(5207):742–745. doi: 10.1038/223742b0. [DOI] [PubMed] [Google Scholar]
  19. Morgan H. C. Estimation of renal function using phenolsulphonphthalein (PSP). Vet Med Small Anim Clin. 1968 Apr;63(4):356–361. [PubMed] [Google Scholar]
  20. Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969 Jul 5;223(5201):29–35. doi: 10.1038/223029a0. [DOI] [PubMed] [Google Scholar]
  21. Piper P. J., Vane J. R., Wyllie J. H. Inactivation of prostaglandins by the lungs. Nature. 1970 Feb 14;225(5233):600–604. doi: 10.1038/225600a0. [DOI] [PubMed] [Google Scholar]
  22. RIVERA-ESTRADA C., SALTZMAN P. W., SINGER D., KATZ L. N. Action of hypoxia on the pulmonary vasculature. Circ Res. 1958 Jan;6(1):10–14. doi: 10.1161/01.res.6.1.10. [DOI] [PubMed] [Google Scholar]
  23. Said S. I. The lung in relation to vasoactive hormones. Fed Proc. 1973 Sep;32(9):1972–1976. [PubMed] [Google Scholar]
  24. Said S. I., Yoshida T., Kitamura S., Vreim C. Pulmonary alveolar hypoxia: release of prostaglandins and other humoral mediators. Science. 1974 Sep 27;185(4157):1181–1183. doi: 10.1126/science.185.4157.1181. [DOI] [PubMed] [Google Scholar]
  25. Sharma S. D., Hale R. W. Early mid trimester abortion - by intramuscular 15 methyl prostaglandin E2. Prostaglandins. 1974 Oct 25;8(2):171–178. doi: 10.1016/0090-6980(74)90078-1. [DOI] [PubMed] [Google Scholar]
  26. Van Creveld S., Pascha C. N. Influence of the prostaglandins E1 and E2 on aggregation of blood platelets. Nature. 1968 Apr 27;218(5139):361–362. doi: 10.1038/218361a0. [DOI] [PubMed] [Google Scholar]
  27. Weeks J. R., DuCharme D. W., Magee W. E., Miller W. L. The biological activity of the (15S)-15-methyl analogs of prostaglandins. E2 and F2a. J Pharmacol Exp Ther. 1973 Jul;186(1):67–74. [PubMed] [Google Scholar]
  28. Weeks J. R. Prostaglandins. Annu Rev Pharmacol. 1972;12:317–336. doi: 10.1146/annurev.pa.12.040172.001533. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES